HSTM

AI Memo

HealthStream

As of 2026-07-16/Confidence medium

Open ticker Back to Memos

Data freshness

AI Memo

As of 2026-07-16 • Model: RankAlpha Sentiment Codex

Decision Panel

Action, confidence, horizon, and decision blockers at a glance.

Action

—

Confidence

medium

Horizon

—

Key catalyst

Next earnings report tests whether Q1 momentum is durable • 2026-10-05

Expected move: +12%

Biggest risk

The positive setup depends on sustaining subscription growth and integrating recent acquisitions while increasing investment in sales, career networks, and AI. Low coverage, unavailable analyst revisions, and limited forward evidence raise the risk that a guidance-confirming quarter is required before further upside.

Invalidation

Break below $26 or thesis failure.

What would change my mind?

Q1 showed record revenue and adjusted EBITDA, strong subscription growth, acquisition contribution, and reaffirmed FY2026 guidance. Continued subscription execution plus successful integration and cross-sell could support a move toward the low-to-mid $30s. [#PR-EARNINGS-2026-05-06]

Research note

Recommendation

—

Confidence

medium

As of

2026-07-16

Base target

$32

p=50%

Bull target

$35

p=25%

Bear target

$26

p=25%

Key bullets

Fast scan of bull, bear, and watch items

BullKey bullets

Reaffirmed FY2026 outlook provides near-term support
Acquisition integration and platform cross-sell
Q1 showed record revenue and adjusted EBITDA, strong subscription growth, acquisition contribution, and reaffirmed FY2026 guidance.

BearKey bullets

Analyst coverage and revision data are unavailable, limiting confidence in the target-price signal.
FY2026 guidance could be vulnerable if demand, margins, or execution weaken.
Integration and cross-sell benefits from Virsys12 and MissionCare Collective may not scale as expected.

WatchKey bullets

Next earnings report tests whether Q1 momentum is durable

Summary

High-level snapshot

Recommendation

Model confidence

medium

Timeframe

Asset

Equity

Trigger

Base case: $32 (p=50%)

Bull/Bear spread: +23% / -10%

Vs latest close: Bull +23% · Base +12% · Bear -10%

Scenario probabilities

Bull Target: $35 (p=25%)Base Target: $32 (p=50%)Bear Target: $26 (p=25%)

Commentary

News tone is mildly constructive because Q1 results were described as record-setting and FY2026 guidance was reaffirmed, but headline volume is low. No usable social, options, short-interest, employee, or analyst-revision data was provided; missing market-reaction and revision evidence keeps this a cautious monitoring view.

As of 2026-07-16 • Updated bi-weekly / post-earningsSource: Internal modelMethodology

Analyst Summary

Thesis highlights from the latest analysis

Bull Case

Bear Case

Drivers

Scannable catalysts and supporting factors

Reaffirmed FY2026 outlook provides near-term support
Acquisition integration and platform cross-sell

Scenarios

Bull Target (Scenario probability)

$35 / p=25% prob

Base Target (Scenario probability)

$32 / p=50% prob

Bear Target (Scenario probability)

$26 / p=25% prob

Price $28 as of 2026-07-17

Nearest Scenario: Bear (∆ 10%)

Targets vs latest close: Bull +23% · Base +12% · Bear -10%

Sentiment & Exposure

News Sentiment (30d)

0.55

Social Sentiment (7d)

0.00

Events

Other notable items detected

EVENT2026-10-05
Next earnings report tests whether Q1 momentum is durable
The next quarterly report is the key forward checkpoint for subscription growth, acquisition contribution, margins, and maintenance of FY2026 guidance. Q1 results were accompanied by reaffirmed full-year guidance in the May 4 8-K. [#SEC-8K-2026-05-04]
Prob 60.00% • Move 8.00% • Priced-in 55.00%

Short-term Catalysts

Next few weeks

Reaffirmed FY2026 outlook provides near-term support
2026-10-14
The May 4 filing confirms that HealthStream announced Q1 results and reaffirmed its FY2026 outlook; this supports sentiment while investors await further operating confirmation, but is largely known and is not a standalone rerating catalyst. [#SEC-8K-2026-05-04]
Prob 70% • Move 3% • Priced-in 75%

Long-term Catalysts

Months to a year

Acquisition integration and platform cross-sell
2027-07-07
Virsys12 and MissionCare Collective broadened HealthStream into payer credentialing and career-network workflows. Stored earnings-call context cites $3.4 million of Q1 contribution and continued integration and cross-sell opportunities, but execution remains unproven. [#PR-EARNINGS-2026-05-06]
Prob 55% • Move 12% • Priced-in 40%

Risks

Analyst coverage and revision data are unavailable, limiting confidence in the target-price signal.
FY2026 guidance could be vulnerable if demand, margins, or execution weaken.
Integration and cross-sell benefits from Virsys12 and MissionCare Collective may not scale as expected.
Next results could show slower subscription growth, weaker acquisition contribution, or pressure from increased growth and AI investment.

Peers

Symbol	Summary
INMD	Closer in market capitalization than business model; its elective-device exposure makes it a loose health-care valuation and risk comparator rather than a direct peer.
BBNX	Small-cap health-care exposure provides a broad size and execution comparator, but its diabetes-device model is not directly comparable with HealthStream's subscription workforce platform.
AVR	Similar sector and approximate market-cap range, but its cardiovascular-device profile offers limited operating read-through to HealthStream.

Sources

Internal and external references used in this analysis

Model source: RankAlpha Sentiment Codex
Analysis date: 2026-07-16

AI Stock Memo: HSTM - HealthStream - RankAlpha